Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase EARLY_PHASE1 2Phase 3 1Phase 1/2 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Lymphoid 1Head & Neck 1

Conditions

Thyroid Diseases 1Neuroma, Acoustic 1Brain Neoplasms 1Adenolymphoma 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Fluorescein × Clear all
NCT06054178 2026-05-20

Identification of Nerves Using Fluorescein Sodium

Stanford University

Phase 2 Completed
8 enrolled 9 charts
Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

NCT04351373 2023-08-01

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

Mayo Clinic

Phase 2 Completed
12 enrolled 11 charts
CNS

Neuroma, Acoustic

NCT04597801 2022-11-10

INVIVO

Technical University of Munich

Phase 2 Completed
210 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡